Production of rare ginsenosides by biotransformation of Panax notoginseng saponins using Aspergillus fumigatus

Abstract

Panax notoginseng saponins (PNS) are the main active components of Panax notoginseng. But after oral administration, they need to be converted into rare ginsenosides by human gut microbiota and gastric juice before they can be readily absorbed into the bloodstream and exert their effects. The sources of rare ginsenosides are extremely limited in P. notoginseng and other medical plants, which hinders their application in functional foods and drugs. Therefore, the production of rare ginsenosides by the transformation of PNS using Aspergillus fumigatus was studied in this research. During 50 days at 25 ℃ and 150 rpm, A. fumigatus transformed PNS to 14 products (1–14). They were isolated by varied chromatographic methods, such as silica gel column chromatography, Rp-C₁₈ reversed phase column chromatography, semi-preparative HPLC, Sephadex LH-20 gel column chromatography, and elucidated on the basis of their ¹H-NMR, ¹³C-NMR and ESIMS spectroscopic data. Then, the transformed products (1–14) were isolated and identified as Rk₃, Rh₄, 20 (R)-Rh₁, 20 (S)-Protopanaxatriol, C-K, 20 (R)-Rg₃, 20 (S)-Rg₃, 20 (S)-Rg₂, 20 (R)-R₂, Rk₁, Rg₅, 20 (S)-R₂, 20 (R)-Rg₂, and 20 (S)-I_, respectively. In addition, all transformed products (1–14) were tested for their antimicrobial activity. Among them, compounds 5 (C-K) and 7 [20 (S)-Rg₃] showed moderate antimicrobial activities against Staphylococcus aureus and Candida albicans with MIC values of 6.25, 1.25 μg/mL and 1.25, 25 μg/mL, respectively. This study lays the foundation for production of rare ginsenosides.

Keywords

Panax notoginseng saponins / Biotransformation / Rare ginsenosides / Aspergillus fumigatus / Antimicrobial activity

References

[1] Chen GT, Yang M, Lu ZQ, Zhang JQ, Huang HL, Liang Y, Guan SH, Song Y, Wu LJ, Guo DA. Microbial transformation of 20 (S)-Protopanaxatriol-Type Saponins by Absidia coerulea. J Nat Prod, 2007, 70: 1203-1206.

[2] Cui L, Wu SQ, Zhao CA, Yin CR (2016) Microbial conversion of major ginsenosides in ginseng total saponins by Platycodon grandiflorum endophytes. J Ginseng Res 40:366–374. https://doi.org/10.1016/j.jgr.2015.11.004

[3] Duan ZG, Wei B, Deng JJ, Mi Y, Dong YF, Zhu CH, Fu RZ, Qu LL, Fan DD. The anti-tumor effect of ginsenoside Rh₄ in MCF-7 breast cancer cells in vitro and in vivo. Biochem Bioph Res Co, 2018, 499: 482-487.

[4] Jiang YY, Li WN, Fan DD. Biotransformation of Ginsenoside Rb₁ to Ginsenoside CK by Strain XD101: a safe bioconversion strategy. Appl Biochem Biotech, 2021, 193: 2110-2127.

[5] Kim SI, Park JH, Ryu JH, Park JD, Lee YH, Park JH, Kim TH, Kim JM, Baek NI. Ginsenoside Rg₅, a genuine dammarane glycoside from Korean red ginseng. Arch Pharm Res, 1996, 19: 551-553.

[6] Li W, Wu XL, Wu MF, Yin JX, Ding H, Wu T, Bie ST, Li FY, He YZ, Han LF, Yang WZ, Song XB, Yu SH, Li Z. Ultrahigh-performance liquid chromatography coupled to ion mobility quadrupole time-of-flight mass spectrometry profiling and unveiling the transformation of ginsenosides by the dual conditions of citric acid and high-pressure steaming. Rapid Commun Mass Sp, 2022, 36.

[7] Li YF, Liang YZ, Cui XM, Shao LJ, Lou DJ, Yang XY. Production of Minor Ginsenosides from Panax notoginseng Flowers by Cladosporium xylophilum. Molecules, 2022, 27: 6615.

[8] Li YW, Guo QW, Huang JQ, Wang ZY. Antidepressant active ingredients from Chinese traditional herb Panax Notoginseng: a pharmacological mechanism review. Front Pharmacol, 2022, 13.

[9] Lin FJ, Guo XY, Lu WY. Efficient biotransformation of ginsenoside Rb₁ to Rd by isolated Aspergillus versicolor, excreting β-glucosidase in the spore production phase of solid culture. Anton Leeuw Int J G, 2015, 108: 1117-1127.

[10] Park IIH, Kim NY, Han SB, Kim JM, Kwon SW, Kim HJ, Park MK, Park JH. Three new dammarane glycosides from heat processed ginseng. Arch Pharm Res, 2002, 25: 428-432.

[11] Park CS, Yoo MH, Noh KH, Oh DK. Biotransformation of ginsenosides by hydrolyzing the sugar moieties of ginsenosides using microbial glycosidases. Appl Microbiol Biot, 2010, 87: 9-19.

[12] Song WS, Shin KC, Oh DK. Production of ginsenoside compound K from American ginseng extract by fed-batch culture of Aspergillus tubingensis. AMB Express, 2023, 13: 64.

[13] Teng RW, Li HZ, Chen JT, Wang DZ, He YN, Yang CR. Complete assignment of ¹H and ¹³C NMR data for nine protopanaxatriol glycosides. Magn Reson Chem, 2002, 40: 483-488.

[14] Teng RW, Ang C, McManus D, Armstrong D, Mau S, Bacic A. Regioselective acylation of Ginsenosides by Novozyme 435 to generate molecular diversity. Helv Chim Acta, 2004, 87: 1860-1872.

[15] Upadhyaya J, Kim MJ, Kim YH, Ko SR, Park HW, Kim MK. Enzymatic formation of compound-K from ginsenoside Rb₁ by enzyme preparation from cultured mycelia of Armillaria mellea. J Ginseng Res, 2016, 40: 105-112.

[16] Usami Y, Liu YN, Lin AS, Shibano M, Akiyama T, Itokawa H, Morris-Natschke SL, Bastow K, Kasai R, Lee KH. Antitumor agents. 261. 20 (S)-Protopanaxadiol and 20 (S)-Protopanaxatriol as antiangiogenic agents and total assignment of ¹H NMR Spectra. J Nat Prod, 2008, 71: 478-481.

[17] Wang W, Zhao YQ, Rayburn ER, Hill DL, Wang H, Zhang RW. In vitro anti-cancer activity and structure–activity relationships of natural products isolated from fruits of Panax ginseng. Cancer Chemoth Pharm, 2007, 59: 589-601.

[18] Wei Y, Zhao WQ, Zhang Q, Zhao YQ, Zhang YX. Purification and characterization of a novel and unique ginsenoside Rg₁-hydrolyzing beta-D-glucosidase from Penicillium sclerotiorum. Acta Bioch Bioph Sin, 2011, 43: 226-231.

[19] Wei YZ, Yang MZ, Yuan W. Network Pharmacological Study of the active Ingredient of Panax Notoginseng Saponins for the treatment of lung cancer by Inhibiting AKR1C3. Lett Drug Des Discov, 2023

[20] Wu LP, Jin Y, Yin CR, Bai LL. Co-transformation of Panax major ginsenosides Rb₁ and Rg₁ to minor ginsenosides C-K and F₁ by Cladosporium cladosporioides. J Ind Microbiol Biot, 2012, 39: 521-527.

[21] Xiong Y, Chen LJ, Man JH, Hu YP, Cui XM. Chemical and bioactive comparison of Panax notoginseng root and rhizome in raw and steamed forms. J Ginseng Res, 2019, 43: 385-393.

[22] Yang F, Ma Q, Matsabisa MG, Chabalala H, Braga FC, Tang MK. Panax notoginseng for cerebral ischemia: a systematic review. Am J Chinese Med, 2020, 48: 1331-1351.

[23] Yang XW, Li LY, Tian JM, Zhang ZW, Ye JM, Gu WF. Ginsenoside-Rg₆, a novel triterpenoid saponin from the stem-leaves of Panax ginseng C.A.Mey. Chinese Chem Lett, 2000, 11: 909-912.

[24] Ye L, Zhou CQ, Zhou W, Zhou P, Chen DF, Liu XH, Shi XL, Feng MQ. Biotransformation of ginsenoside Rb₁ to ginsenoside Rd by highly substrate-tolerant Paecilomyces bainier 229–7. Bioresource Technol, 2010, 101: 7872-7876.

[25] Yoshikawa M, Murakami T, Ueno T, Hirokawa N, Yashiro K, Murakami N, Yamahara J, Matsuda H, Saijoh R, Tanaka O. Bioactive saponins and glycosides.IX. Notoginseng (2): structures of five new dammarane-type triterpene oligoglycosides, notoginsenosides-E, -G, -H, -I, and -J, and a novel acetylenic fatty acid glycoside, notoginsenic acid β-sophoroside from the dried root of Panax notoginseng (BURK.) F.H.Chen. Chem Pharm Bull, 1997, 45: 1056-1062.

[26] Zhang L, Wang LW, Chen YF, Yang YY, Xia GH, Guo YA, Yang H, Shen YP, Meyer AS. Biotransformation of ginsenoside Rb₁ and Rd to four rare ginsenosides and evaluation of their anti-melanogenic effects. J Nat Med-tokyo, 2023, 77: 939-952.

[27] Zhang X, Xie YF, Dai ZP, Liang Y, Zhu CY, Su C, Song LS, Wang KP, Li J, Wei XY. Gypenoside biotransformation into ginsenoside F₂ by endophytic Aspergillus niger from Gynostemma pentaphyllum. Nat Prod Res, 2023

[28] Zhou W, Feng MQ, Li XW, Yan Q, Zhou CQ, Li JY, Zhou P. X-ray structure investigation of (20 S)-20-O-beta-D-glucopyranosyl-protopanaxadiol and antitumor effect on Lewis lung carcinoma in vivo. Chem Biodivers, 2009, 6: 380-388.

Funding

National Natural Science Foundation of China(32060104)